Bodies as means for continuing post-death relationships.

Secondary analysis of data from 30 people in three interview studies shows that bereaved people use their own and the deceased's body in their continuing efforts to maintain a relationship with the departed. Following the continuing bond perspective, the study reveals three body-associated strategies for maintaining post-death relationships: (a) the presence of the deceased in the bereaved's body, (b) body-associated actions and activities, and (c) sensing and caring for the deceased's body. The conceptual dimension of embodiment is used to interpret results.

Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment.

A group of 133 patients with benign prostatic hyperplasia who were either poor operative risks or who had refused surgery underwent localised deep microwave hyperthermia, without supplementary drugs. In 59% of patients who had had an indwelling catheter, freedom from urological obstruction and satisfactory voiding were maintained for 7 years and catheterisation was not required. In patients with severe prostatic symptoms, 65% showed general improvement and satisfactory voiding for 8 years.

[Noninvasive, local microwave hyperthermia for deep-seated tumors: III. Benign prostatic hyperplasia].

Poor operative risk patients with benign prostatic hyperplasia were treated as outpatients with local hyperthermia without sedation, for 1 hour, twice weekly. As a result of the treatment it was possible in 61% to remove indwelling catheters and voiding was resumed for up to 61 months after treatment. 70% of those without indwelling catheters improved clinically and remained so for 67 months after completion of treatment.

[Local hyperthermia of upper respiratory passages for perennial allergic rhinitis].

Local hyperthermia (43 degrees C) to the upper respiratory passages, without supplementary drugs, relieves symptoms of perennial allergic rhinitis. Treatment consisted of 3, 30 minute sessions at 1-hour intervals during a single day. 69% were free of their symptoms during the month following treatment, and 52, 37 and 28% were free for 4, 8 and 12 months, respectively.